<DOC>
	<DOCNO>NCT02558491</DOCNO>
	<brief_summary>The purpose study demonstrate safety feasibility decision support system aim reduce glucose variability T1DM patient use insulin pump .</brief_summary>
	<brief_title>Feasibility Decision Support System Reduce Glucose Variability Subject With T1DM</brief_title>
	<detailed_description>The overall aim propose research demonstrate safety feasibility decision support system aim reduce glucose variability T1DM patient use insulin pump . The system deploy portable medical application platform ( DiAs ) include insulin pump treatment parameter optimization exercise risk warning system , capable predict hypoglycemia onset physical activity advise mitigate alteration treatment . A second phase trial enroll additional user insulin pump , subject treat T1DM use multiple daily injection ( MDI ) insulin . MDI user administer Lantus ( glargine ) dose approximately time day use one basal rate per day . MDI user also use MySugr app count carbohydrates meal require insulin treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Clinical diagnosis base investigator assessment , type 1 diabetes least one year either use insulin pump therapy least 6 month MDI therapy ( consist Lantus [ glargine ] , Tresiba [ degludec ] , Levemir [ Detemir ] plus rapidacting meal insulin ) least 6 month ; 12 basal insulin injection per day , consistent timing amount . A . Historical criterion document hyperglycemia ( least 1 must meet ) : i. Fasting glucose ≥126 mg/dL . ii . Twohour OGTT glucose ≥200 mg/dL . iii . Hemoglobin A1c ≥6.5 % document . iv . Random glucose ≥200 mg/dL symptom . v. No data diagnosis available participant convince history hyperglycemia consistent diabetes . B . Historical criterion require insulin diagnosis ( 1 must meet ) : . Participant required insulin diagnosis continually thereafter . ii . Participant start insulin diagnosis upon investigator review likely need insulin ( significant hyperglycemia respond oral agent ) require insulin eventually use continually . iii . Participant start insulin diagnosis continue hyperglycemic , positive islet cell antibody consistent latent autoimmune diabetes adult ( LADA ) require insulin eventually use continually . 2 . Age 21 65years old . 3 . Females , currently know pregnant . If female sexually active , must agree use form contraception prevent pregnancy participate study . A negative urine/blood pregnancy test require premenopausal woman surgically sterile . Subjects become pregnant discontinue study . 4 . Demonstration proper mental status cognition study 5 . MDI subject administer Lantus ( glargine ) , Tresiba [ degludec ] , Levemir [ Detemir ] dose approximately time day . 6 . CSII subject must currently use bolus calculator function current insulin pump predefined parameter glucose goal , carbohydrate ratio , insulin sensitivity factor . 7 . MDI user must currently use Intensive Insulin Therapy include carbohydrate counting use predefined parameter glucose goal , carbohydrate ratio , insulin sensitivity factor . 8 . Willing use Humalog ( lispro ) Novolog ( aspart ) insulin study procedure MDI subject . 9 . CSII subject must willing use current bolus calculator pump parameter enter carbohydrate intake pump 28 day data collection period . 10 . MDI user must willing use carbohydrate counting parameter meal dose enter information MySugr app . 11 . Ability access Internet provide data clinical team travel research center study equipment personal pump download . 12 . An understanding willingness follow protocol sign inform consent . The presence follow exclusion study : 1 . Diabetic ketoacidosis ( DKA ) 6 month prior enrollment . 2 . Severe hypoglycemia result seizure loss consciousness 6 month prior enrollment . 3 . Current treatment seizure disorder . 4 . Coronary artery disease heart failure , unless write clearance receive cardiologist . 5 . Atrial ventricular arrhythmia ( benign premature atrial contraction [ PACs ] premature ventricular contraction [ PVCs ] allow ) 6 . Cystic fibrosis . 7 . Pregnancy , breastfeeding , intention become pregnant time study procedure . 8 . A known medical condition judgment investigator might interfere completion protocol follow example : i. Inpatient psychiatric treatment past 6 month ii . Presence known adrenal disorder iii . Abnormal liver function test result ( Transaminase &gt; 2 time upper limit normal ) ; test require subject take medication know affect liver function diseases know affect liver function iv . Abnormal renal function test result ( calculated GFR &lt; 60 mL/min/1.73m2 ) ; test require subject diabetes duration great 5 year post onset puberty v. Active gastroparesis vi . If antihypertensive , thyroid , antidepressant lipid lower medication , lack stability medication past 2 month prior enrollment study vii . Uncontrolled thyroid disease ( TSH undetectable &gt; 10 mlU/L ) ; test require within three month prior admission subject goiter , positive antibody , thyroid hormone replacement , within one year otherwise viii . Abuse alcohol recreational drug ix . Infectious process anticipate resolve prior study procedure ( e.g . meningitis , pneumonia , osteomyelitis , deep tissue infection ) . x. Uncontrolled arterial hypertension ( Resting diastolic blood pressure &gt; 100 mmHg and/or systolic blood pressure &gt; 180 mmHg ) . xi . Oral steroid xii . Uncontrolled microvascular complication current active proliferative diabetic retinopathy define proliferative retinopathy require treatment ( e.g . laser therapy ) past 12 month . 9 . A recent injury body limb , muscular disorder , use medication , carcinogenic disease , significant medical disorder injury , medication disease judgment investigator affect completion protocol . 10 . Basal Rates &lt; 0.01 units/hour CSII subject . 11 . More one basal dose per day MDI subject 12 . Allergy intolerance Novolog ( aspart ) Humalog ( lispro ) insulin MDI subject . 13 . Diagnosed food allergy . 14 . Current use follow drug supplement : . Regular acetaminophen user , willing suspend acetaminophen 24 hour entire length trial ii . Any medication investigator believe contraindication subject 's participation 15 . Any reason study MD considers subject properly fit trial ( i.e . insulin pump record need trial ) . 16 . Current enrollment another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Type 1 Diabetes Mellitus ( T1DM )</keyword>
	<keyword>Artificial Pancreas Project ( APP )</keyword>
	<keyword>Diabetes Assistant ( DiAs )</keyword>
	<keyword>Insulin Pump</keyword>
	<keyword>Continuous Glucose Monitor</keyword>
	<keyword>Exercise</keyword>
	<keyword>Glucose Variability</keyword>
	<keyword>Decision Support System</keyword>
	<keyword>Multiple Daily Injections ( MDI )</keyword>
</DOC>